Since Ca2+ transfers between the ER and the mitochondria are tightly connected, we speculate that Bcl-xL could inhibit both VDAC1 and IP3Rs in breast cancer cells to promote cancer malignant features. Here, BCL2L1 is linked to breast carcinoma.